On the other hand, several studies based on bioinformatics have revealed a lower survival probability of breast cancer, gastric cancer, mesothelioma, and colorectal cancer patients with higher expression of COL1A1, COL1A2, and COL11A1.79, 80, 81, 82. Here, COL1A2 is linked to colorectal cancer.